Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide - Local Development build (v0.1.0). See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "cfsb1651597532341",
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "EU/1/19/1370/001"
},
"type" : "document",
"timestamp" : "2011-06-23T08:38:00+02:00",
"entry" : [
{
"resource" : {
"resourceType" : "Composition",
"id" : "cfsb1651234995610",
"language" : "es",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"es\" lang=\"es\"><p><b>Generated Narrative: Composition</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition \"cfsb1651234995610\" (Language \"es\") </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2022-04-29 01:28:17+0000</p><p><b>author</b>: <a href=\"#Organization_cfsb1651149636159\">See above (Organization/cfsb1651149636159)</a></p><p><b>title</b>: TEST PURPOSES ONLY/EJEMPLO DE PRUEBAS - Dovato 50 mg/300 mg comprimidos recubiertos con película</p><p><b>confidentiality</b>: U</p><h3>Attesters</h3><table class=\"grid\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-composition-attestation-mode.html\">CompositionAttestationMode</a>#official)</span></td><td>2002-08-01 01:28:17+0000</td></tr></table></div>"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538"
}
],
"text" : "Package Leaflet"
},
"subject" : {
"reference" : "RegulatedAuthorization/cfsb1651148079894"
},
"date" : "2022-04-29T13:28:17Z",
"author" : [
{
"reference" : "Organization/cfsb1651149636159"
}
],
"title" : "TEST PURPOSES ONLY/EJEMPLO DE PRUEBAS - Dovato 50 mg/300 mg comprimidos recubiertos con película",
"confidentiality" : "U",
"attester" : [
{
"mode" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/composition-attestation-mode",
"code" : "official"
}
]
},
"time" : "2002-08-01T13:28:17Z"
}
],
"section" : [
{
"title" : "B. Package Leaflet",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Prospecto: información para el paciente Dovato 50 mg/300 mg comprimidos recubiertos con película dolutegravir/lamivudina <b>Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.</b><ul><li>Conserve este prospecto, ya que puede tener que volver a leerlo.</li><li>Si tiene alguna duda, consulte a su médico o farmacéutico.</li><li>Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.</li><li>Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.</li></ul></div>"
}
},
{
"title" : "What is in this leaflet",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-0"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Contenido del prospecto<ol><li>Qué es Dovato y para qué se utiliza</li><li>Qué necesita saber antes de empezar a tomar Dovato</li><li>Cómo tomar Dovato</li><li>Posibles efectos adversos</li><li>Conservación de Dovato</li><li>Contenido del envase e información adicional</li></ol></div>"
}
},
{
"title" : "1. What Dovato is and what it is used for",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-1"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>1. Qué es Dovato y para qué se utiliza</b> Dovato es un medicamento que contiene dos principios activos usados para tratar la infección por el virus de la inmunodeficiencia humana (VIH): dolutegravir y lamivudina. Dolutegravir pertenece al grupo de medicamentos antirretrovirales llamados inhibidores de la integrasa (INI) y lamivudina pertenece a un grupo de medicamentos antirretrovirales denominados inhibidores de la transcriptasa inversa análogos de nucleósido (ITIAN).</div>"
}
},
{
"title" : "2. What you need to know before you take Dovato",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-2"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>2. Qué necesita saber antes de empezar a tomar Dovato</b> <b>No tome Dovato</b><ul><li>si es <b>alérgico</b> (hipersensible) a dolutegravir o lamivudina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6)</li><li>si está tomando un medicamento llamado <b>fampridina</b> (también conocido como dalfampridina; utilizado para tratar la esclerosis múltiple).</li></ul></div>"
}
},
{
"title" : "3. How to take Dovato",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-3"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>3. Cómo tomar Dovato</b><p>Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.</p><ul><li>La dosis recomendada de Dovato es <b>un comprimido una vez al día.</b></li></ul><p>Trague el comprimido con un poco de líquido. Dovato se puede tomar con o sin alimentos.</p></div>"
}
},
{
"title" : "4. Possible side effects",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-4"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>4. Posibles efectos adversos</b></p><p>Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran, <b>por lo que es muy importante que le comente a su médico cualquier cambio en su estado de salud.</b></p></div>"
}
},
{
"title" : "5. How to store Dovato",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-5"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>5. Conservación de Dovato</b><p>Mantener este medicamento fuera de la vista y del alcance de los niños</p><p>No utilice este medicamento después de la fecha de caducidad que aparece en la caja y el frasco después de CAD. La fecha de caducidad es el último día del mes que se indica.</p><p>Este medicamento no requiere ninguna condición especial de conservación.</p><p>Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.</p></div>"
}
},
{
"title" : "6. Contents of the pack and other information",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/",
"code" : "100000155538-6"
}
],
"text" : "B. PACKAGE LEAFLET"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>6. Contenido del envase e información adicional</b> <b>Composición de Dovato</b><ul><li>Los principios activos son dolutegravir y lamivudina. Cada comprimido contiene dolutegravir sódico equivalente a 50 mg de dolutegravir y 300 mg de lamivudina.</li><li>Los demás componentes son celulosa microcristalina, carboximetilalmidón sódico, estearato de magnesio, manitol (E421), povidona (K29/32), fumarato estearilo de sodio, hipromelosa (E464), macrogol, dióxido de titanio (E171).</li><li>Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.</li></ul></div>"
}
}
]
}
},
{
"resource" : {
"resourceType" : "Organization",
"id" : "cfsb1650997423990",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization \"cfsb1650997423990\" </p></div><p><b>identifier</b>: id: ORG-100004538 (OFFICIAL), id: LOC-100000153 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: manufacturer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000033)</span></p><p><b>name</b>: GLAXO WELLCOME, S.A.</p><p><b>address</b>: Avda. Extremadura, 3(WORK)</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "$spor-org",
"value" : "ORG-100004538"
},
{
"use" : "official",
"system" : "$spor-org",
"value" : "LOC-100000153"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000033"
}
],
"text" : "manufacturer"
}
],
"name" : "GLAXO WELLCOME, S.A.",
"address" : [
{
"use" : "work",
"type" : "physical",
"text" : "Avda. Extremadura, 3",
"line" : [
"Avda. Extremadura 3, 09400 Aranda De Duero"
],
"city" : "Aranda De Duero",
"country" : "ES"
}
]
}
},
{
"resource" : {
"resourceType" : "Organization",
"id" : "cfsb1651152112409",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization \"cfsb1651152112409\" </p></div><p><b>identifier</b>: id: ORG-100013412 (OFFICIAL), id: LOC-100020264 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000032)</span></p><p><b>name</b>: European Medicines Agency</p><p><b>address</b>: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "ORG-100013412"
},
{
"use" : "official",
"system" : "$spor-org",
"value" : "LOC-100020264"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "/#220000000032"
}
],
"text" : "Medicines Regulatory Authority"
}
],
"name" : "European Medicines Agency",
"address" : [
{
"use" : "work",
"type" : "physical",
"text" : "Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands",
"line" : [
"Carretera De Martorell 41 61, Poligono Industrial Nord-Est"
],
"city" : "Amsterdam",
"postalCode" : "1083 HS",
"country" : "nl"
}
]
}
},
{
"resource" : {
"resourceType" : "Organization",
"id" : "cfsb1651149636159",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Organization</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization \"cfsb1651149636159\" </p></div><p><b>identifier</b>: id: ORG-100012958 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000034)</span></p><p><b>name</b>: ViiV Healthcare BV</p><p><b>address</b>: Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands(WORK)</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "ORG-100012958"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000034",
"display" : "Marketing authorisation holder"
}
],
"text" : "Marketing authorisation holder"
}
],
"name" : "ViiV Healthcare BV",
"address" : [
{
"use" : "work",
"type" : "physical",
"text" : "Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands",
"line" : [
"Van Asch van Wijckstraat 55H"
],
"city" : "Amersfoort",
"country" : "NL"
}
]
}
},
{
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "cfsb1651148079894",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization \"cfsb1651148079894\" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>subject</b>: <a href=\"#MedicinalProductDefinition_cfsb1650904258324\">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000072062)</span></p><p><b>region</b>: European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2019-07-01 01:28:17+0000</p><p><b>holder</b>: <a href=\"#Organization_cfsb1651149636159\">See above (Organization/cfsb1651149636159)</a></p><p><b>regulator</b>: <a href=\"#Organization_cfsb1651152112409\">See above (Organization/cfsb1651152112409)</a></p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/19/1370/001"
}
],
"subject" : [
{
"reference" : "MedicinalProductDefinition/cfsb1650904258324"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072062"
}
],
"text" : "Marketing Authorisation"
},
"region" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "eu"
}
],
"text" : "European Union"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active"
}
],
"text" : "Active"
},
"statusDate" : "2019-07-01T13:28:17Z",
"holder" : {
"reference" : "Organization/cfsb1651149636159"
},
"regulator" : {
"reference" : "Organization/cfsb1651152112409"
}
}
},
{
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "cfsb1650904258324",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicinalProductDefinition</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicinalProductDefinition \"cfsb1650904258324\" </p></div><p><b>identifier</b>: id: 498163</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-medicinal-product-type.html\">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-medicinal-product-domain.html\">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Dovato 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000001)</span></p><h3>NameParts</h3><table class=\"grid\"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>film-coated tablets</td><td>Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class=\"grid\"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "498163"
}
],
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-type",
"code" : "MedicinalProduct"
}
],
"text" : "Medicinal Product"
},
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human"
}
],
"text" : "Human use"
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072084"
}
],
"text" : "Medicinal product subject to medical prescription"
},
"name" : [
{
"productName" : "Dovato 50 mg/300 mg film-coated tablets",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000001"
}
],
"text" : "Full name"
},
"namePart" : [
{
"part" : "film-coated tablets",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000005"
}
],
"text" : "Pharmaceutical dose form part"
}
}
],
"countryLanguage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "eu"
}
],
"text" : "European Union"
},
"jurisdiction" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "eu"
}
],
"text" : "European Union"
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en"
}
],
"text" : "English"
}
}
]
}
]
}
},
{
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "cfsb1650995718524",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PackagedProductDefinition</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PackagedProductDefinition \"cfsb1650995718524\" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>name</b>: Dovato 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Chemical Medicinal Prodcut <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000155527)</span></p><p><b>packageFor</b>: <a href=\"#MedicinalProductDefinition_cfsb1650904258324\">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2012-02-07 01:28:17+0000</p><p><b>containedItemQuantity</b>: 30 tablets</p><p><b>manufacturer</b>: <a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></p><h3>Packages</h3><table class=\"grid\"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id: 654321</td><td>Child-resistant closure <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000073504)</span></td><td>1</td><td>Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#200000003529)</span></td></tr></table></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "$spor-prod",
"value" : "EU/1/19/1370/001"
}
],
"name" : "Dovato 50 mg/300 mg film-coated tablets",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155527"
}
],
"text" : "Chemical Medicinal Prodcut"
},
"packageFor" : [
{
"reference" : "MedicinalProductDefinition/cfsb1650904258324"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2012-02-07T13:28:17Z",
"containedItemQuantity" : [
{
"value" : 30,
"unit" : "tablets"
}
],
"manufacturer" : [
{
"reference" : "Organization/cfsb1650997423990"
}
],
"package" : {
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "654321"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073504",
"display" : "Child-resistant closure"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
]
}
}
},
{
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "cfsb1650999516847",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: AdministrableProductDefinition</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource AdministrableProductDefinition \"cfsb1650999516847\" </p></div><p><b>identifier</b>: id: 123456</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\"#MedicinalProductDefinition_cfsb1650904258324\">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>administrableDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#10219000)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#15054000)</span></p><p><b>producedFrom</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#20053000)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000109093)</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "https://www.who-umc.org/phpid",
"value" : "123456"
}
],
"status" : "active",
"formOf" : [
{
"reference" : "MedicinalProductDefinition/cfsb1650904258324"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://standardterms.edqm.eu/browse/get_concepts_by/SOM/SOM/",
"code" : "10219000"
}
],
"text" : "Tablet"
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://standardterms.edqm.eu/browse/get_concepts/UOP/",
"code" : "15054000"
}
],
"text" : "Tablet"
},
"producedFrom" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://standardterms.edqm.eu/browse/get_concepts/ROA/",
"code" : "20053000"
}
],
"text" : "Oral use"
},
"targetSpecies" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "/#100000109093"
}
],
"text" : "Human"
}
}
]
}
]
}
},
{
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "cfsb1650998521654",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ManufacturedItemDefinition</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ManufacturedItemDefinition \"cfsb1650998521654\" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Film-coated tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073665)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#200000002152)</span></p><p><b>manufacturer</b>: <a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi/#/",
"value" : "EU/1/19/1370/001"
}
],
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000073665"
}
],
"text" : "Film-coated tablet"
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000002152"
}
],
"text" : "Tablet"
},
"manufacturer" : [
{
"reference" : "Organization/cfsb1650997423990"
}
]
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651162710491",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651162710491\" </p></div><p><b>identifier</b>: id: 1Q1V9V5WYQ (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#00000072072)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>50 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity##ACTIB)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "1Q1V9V5WYQ"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "00000072072"
}
],
"text" : "active"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "1Q1V9V5WYQ",
"display" : "DOLUTEGRAVIR SODIUM"
}
]
}
},
"strength" : [
{
"presentationQuantity" : {
"value" : 50,
"unit" : "mg"
},
"basis" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity",
"code" : "#ACTIB"
}
],
"text" : "active ingredient - basis of strength"
}
}
]
}
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651164758053",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651164758053\" </p></div><p><b>identifier</b>: id: 2T8Q726O95 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072072)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>300 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity##ACTIB)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "2T8Q726O95"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000072072"
}
],
"text" : "active"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "2T8Q726O95",
"display" : "lamivudine"
}
]
}
},
"strength" : [
{
"presentationQuantity" : {
"value" : 300,
"unit" : "mg"
},
"basis" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity",
"code" : "#ACTIB"
}
],
"text" : "active ingredient - basis of strength"
}
}
]
}
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651170791283",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651170791283\" </p></div><p><b>identifier</b>: id: OP1R32D61U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "OP1R32D61U"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000072082"
}
],
"text" : "Excipient"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "OP1R32D61U",
"display" : "microcrystalline cellulose"
}
]
}
}
}
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651229974487",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651229974487\" </p></div><p><b>identifier</b>: id: H8AV0SQX4D (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "H8AV0SQX4D"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000072082"
}
],
"text" : "Excipient"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "H8AV0SQX4D",
"display" : "sodium starch glycolate"
}
]
}
}
}
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651230170831",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651230170831\" </p></div><p><b>identifier</b>: id: 70097M6I30 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "70097M6I30"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000072082"
}
],
"text" : "Excipient"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "70097M6I30",
"display" : "magnesium stearate"
}
]
}
}
}
}
},
{
"resource" : {
"resourceType" : "Ingredient",
"id" : "cfsb1651230330246",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Ingredient</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient \"cfsb1651230330246\" </p></div><p><b>identifier</b>: id: 3OWL53L36A (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_cfsb1650998521654\">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb1650997423990\">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "3OWL53L36A"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/cfsb1650998521654"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000072082"
}
],
"text" : "Excipient"
},
"manufacturer" : [
{
"manufacturer" : {
"reference" : "Organization/cfsb1650997423990"
}
}
],
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "3OWL53L36A",
"display" : "mannitol"
}
]
}
}
}
}
}
]
}
IG © 2021+ . Package hl7.fhir.uv.vulcan-epi#0.1.0 based on FHIR 5.0.0-snapshot1. Generated 2022-09-02
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change